• Skip to main content
  • Skip to footer
UK Plans to phase out animal testing UK Plans to phase out animal testing
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Products
    • PhysioMimix® Core Microphysiological System
    • Consumables
      • PhysioMimix® Multi-chip plates
      • 3D validated cells
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Discover the applications


Investigate the validated core application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix Core

cnb1476_physiomimix-core_mark_mocks_system_v2
Learn more

Consumables

Multi-chip plates
3D validated cells
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

May 29, 2026

Event > Conference >

UK Microfluidics Conference 2026


This annual event brings together academic innovators and sector leaders to bridge the gap between scientific breakthroughs and real-world industrial impact.

UK Microfluidics conference 2026 Logo | UK Microfluidics Conference 2026
19 June, 2026
Manchester, UK
Book a meeting

Satellite Workshop: Engaging with the Microfluidics Industry

We’re excited to present at the 3rd UK Microfluidics Conference 2026 Satellite workshop: Engaging with the Microfluidics Industry!

Microfluidics and lab-on-a-chip technologies are central to modern research. They create a vital link between laboratory discovery and commercial reality. This annual event brings together academic innovators and sector leaders to bridge the gap between scientific breakthroughs and real-world industrial impact. The workshop’s core themes include fostering deep collaboration across policy and commercial domains, providing actionable guidance for ecosystem navigation, facilitating high-value networking, and exploring scalable translation pipelines.

This year, the focus of the workshop is the expansion of the UK microfluidics ecosystem at both ends: with researchers gaining clear strategic paths to commercialisation, and industry leaders uncovering new collaborative opportunities to drive growth.


Attend our​ keynote presentation:

The Great Lab Rat Escape – How Microphysiological Systems are Transforming Drug Discovery with Human-Relevant Data

Drug discovery still depends heavily on preclinical models that often fail to predict what happens in humans, contributing to late-stage attrition, escalating costs, and continued reliance on animal testing. Microphysiological systems (MPS), enabled by microfluidics, offer a powerful alternative by recreating key aspects of human physiology in vitro through controlled perfusion, tissue-specific architecture, and organ–organ communication.

In this keynote, Gareth Evans will discuss how MPS are being used to strengthen decision-making in the preclinical stage, where better data can help researchers progress the correct candidates to clinical testing with greater confidence. The talk will showcase how CN Bio is addressing this challenge through PhysioMimix® Core — a unified organ-on-a-chip platform designed to support single-organ, multi-organ, and higher-throughput workflows in a familiar plate-based format. With PDMS-free multi-chip plates, adjustable flow, longitudinal sampling, and compatibility with a wide range of biologically relevant models, the system is designed to combine mechanistic insight with practical scalability.

The session will explore the technical and biological factors that underpin successful adoption, from physiological relevance and reproducibility to automation, throughput and robust biomarker generation, and will consider how these capabilities are helping move MPS towards routine use in modern drug discovery workflows.

Date: 18 June 2026, Thursday

Time: 13:45 – 14:00

Presenters: Dr Gareth Evans


Meet the team at UK Microfluidics Conference 2026:

Gareth E BW | UK Microfluidics Conference 2026

Dr. Gareth Evans

Senior Development Engineer

Gareth Evans is a Senior Development Engineer at CN Bio with over a decade of experience across academia and industry, leading projects from concept through to validated products. He holds a PhD in field-deployable droplet-based microfluidic sensors and has a strong background in developing point-of-care and biochemical assay systems, with experience spanning research, development, and commercialisation. His work focuses on the design and optimisation of complex fluidic architectures that interface with biology.

    Find out more about our PhysioMimx Core

    Find out more about the PhysioMimix Multi-chip (Liver-12, Liver-48, Dual Organ , and Barrier) plates.

    UK Microfluidics Conference 2026

    Book a meeting

    Speak to our experts

    Request a meeting with one of our OOC experts to see how our products and services can support your studies

    Request a meeting

    Footer

    CN Bio logo

    332 Cambridge Science Park, Milton Road
    Cambridge, CB4 0WN

    UK: +44 (0) 1223 737 941

    US: +1 415 523 4005

    Privacy | Cookies | Regulatory | Accessibility
    Website terms | Terms of sale

    Product Recycling

    ©2025 CN Bio Innovations Ltd
    Registered No. ‍06517359. VAT No. GB978184563

    Latest news

    • CN Bio Participating in a New Critical Path Institute Coalition of New Approach Methodologies Developers (NAMs-DC) to Support Advancement in Drug Development May 20, 2026
    • Do MHRA and FDA guidelines on non-animal methods in drug development align? March 27, 2026
    • CN Bio to participate in 3Rs Collaborative-led project with FDA to build confidence in Liver MPS for DILI – now ISTAND accepted! January 25, 2026
    Cyber Essentials Logo

    Modal Title